Shoji, T.; Tatsuki, S.; Abe, M.; Tomabechi, H.; Takatori, E.; Kaido, Y.; Nagasawa, T.; Kagabu, M.; Baba, T.; Itamochi, H.
Novel Therapeutic Strategies for Refractory Ovarian Cancers: Clear Cell and Mucinous Carcinomas. Cancers 2021, 13, 6120.
https://doi.org/10.3390/cancers13236120
AMA Style
Shoji T, Tatsuki S, Abe M, Tomabechi H, Takatori E, Kaido Y, Nagasawa T, Kagabu M, Baba T, Itamochi H.
Novel Therapeutic Strategies for Refractory Ovarian Cancers: Clear Cell and Mucinous Carcinomas. Cancers. 2021; 13(23):6120.
https://doi.org/10.3390/cancers13236120
Chicago/Turabian Style
Shoji, Tadahiro, Shunsuke Tatsuki, Marina Abe, Hidetoshi Tomabechi, Eriko Takatori, Yoshitaka Kaido, Takayuki Nagasawa, Masahiro Kagabu, Tsukasa Baba, and Hiroaki Itamochi.
2021. "Novel Therapeutic Strategies for Refractory Ovarian Cancers: Clear Cell and Mucinous Carcinomas" Cancers 13, no. 23: 6120.
https://doi.org/10.3390/cancers13236120
APA Style
Shoji, T., Tatsuki, S., Abe, M., Tomabechi, H., Takatori, E., Kaido, Y., Nagasawa, T., Kagabu, M., Baba, T., & Itamochi, H.
(2021). Novel Therapeutic Strategies for Refractory Ovarian Cancers: Clear Cell and Mucinous Carcinomas. Cancers, 13(23), 6120.
https://doi.org/10.3390/cancers13236120
